Intrinsiqs

Is DaVita Inc. overvalued?

DaVita Inc. (DVA) looks fairly valued — trading about 5% below its fair value.

Fairly valued
Current price $174.56 Fair value $183.61
Price
$174.56
Fair value
$183.61
Current P/E
14.9
Normal P/E
15.7
Market cap
$10.98B
Dividend yield
0.0%
Return on equity
-133.2%
Sector
Healthcare

See the full interactive analysis →

Fair value compares DVA's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.RHHBY Roche Holding AGUNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.